William Blair Starts LENZ Therapeutics Inc (LENZ) at Outperform, 'emerging leader in eye care'
Tweet Send to a Friend
William Blair analyst Tim Lugo initiates coverage on LENZ Therapeutics Inc (NASDAQ: LENZ) with a Outperform rating.The analyst comments "Lenz ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
